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Kidney transplantation In children. C. Mota, I, Maciel, E. Pereira, C.
Henriques, M. Sarmento, and E. Xavier, Servico de Nefrologia,
Hospital Maria Pia, and Hospital Santo Antonio, Porto, Portugal. We
retrospectively analyzed the results of 30 renal transplants performed in
28 children in the period from 1983 to 1993. The mean age was 13.7
3.1 years old (range 7—18 years), and 80% of these children had been
followed-up in a pre-transplant clinic at the Sick Children's Hospital.
The waiting time for surgery was 20.5 24.3 months. The immunosup-
pressive regimens were as follows: azathioprine + prednisolone (2
patients); cyclosporine (CsA) + prednisolone (11 patients); antithymo-
cite globulin (ATG) + CsA + prednisolone (15 patients); ATG +
azathioprine + CsA + predmsolone (2 patients). The glomerular
function was evaluated by endogenous serum creatinine (mg/lOO ml) at
the third month (1.18 0.26) and at the last visit (1.26 0.26). The rate
of ATN following transplant was 30% with a mean duration time of 10.2
8.2 days. The incidence of acute rejection was 0.66 0.69 episodes/
patient. The graft actuarial survival rate was 83.2% at 1 year and 72.4%
at 8 years of follow-up. The patient actuarial survival rate was 100% and
90.5% at 1 and 8 years, respectively. Conclusions: The waiting time for
transplants has been excessive for a pediatric population. The results of
graft and patient survival are encouraging.
Muckle-Wells syndrome: An infrequent etiology of amylold nephropa-
thy. M. Bustorff, C. Moura, E. Costa, J.P. Oliveira, and L. Guerra,
Servicos de Nefrologia, ORL e Anatomia Patologica e Consulta de
Genética Médica, and Hospital de São João, Porto, Portugal. Muckle-
Wells syndrome (MWS) is a rare autosomal dominant disorder of
unknown pathogenesis, characterized by recurrent attacks of urticarial
rash, frequently associated with arthralgias/arthritis, progressive sen-
sorineural deafness, and, less frequently, amyloid nephropathy. When
present, the renal disease usually follows a rapid course to renal failure.
As in Familial Mediterranean Fever, colchicine therapy may be bene-
ficial regarding the prognosis of renal disease, underscoring the impor-
tance of early diagnosis. Though audiometric abnormalities begin in
childhood, hearing loss may evolve clinically unnoticed for several
years, thus delaying the specific recognition of the syndrome. A 17
year-old girl presented for evaluation of nephrotic syndrome; she had a
history of arthralgias and urticarial rash attacks since infancy. Creati-
nine clearance was normal and she was not hypertensive. Renal biopsy
revealed an AA amyloid nephropathy. None of her two siblings was
affected; her 52 year-old mother had clinically apparent hypoacusia and
a history of similar cutaneous lesions, but no evidence of renal disease.
Audiometric studies showed moderate to severe neurosensorial hearing
loss in both mother and daughter. Colchicine therapy was begun. This
is the first report of MWS in a Portuguese family, and it illustrates that,
because of clinical expression and symptom chronology variability,
diagnosis of individual patients may require a high level of suspicion
and a thorough family investigation.
Time on dialysis is the major risk factor for hepatitis C virus infection
in hemodialysis patients. A. Praca, J.P. Olive Ira, A. Pinho, L. Cordas,
J. Fernandes, A.B. Moreira, J.O. Ferraz, and H. Barros, DRD, Vila do
Conde e Riba de Aye; NMC, Feira; and Servlco de Epidemiologia,
Faculdade de MedicIna, Universidade do Porto, Porto, Portugal.
Objective: To evaluate risk factors for hepatitis C virus (HCV) infection
in a population of patients on chronic hemodialysis. Patients and
methods: 248 patients (M = 159/F = 89; mean age 50.7 years) on
chronic hemodialysis in three outpatient clinics were evaluated regard-
ing time on hemodialysis, total number of previous transfusions, serum
alanine aminotransferase (ALT), serological markers of hepatitis B
virus infection (RIA test) and antibody (Ab) to HCV (ELISA-2). The
risk of infection was estimated by calculation of the odds ratio (OR) in
univariate analysis and multivariate logistic regression. Main results:
Prevalence of HCVAb was 15.7% and did not vary significantly among
each of the participant hemodialysis clinics. HCVAb positive and
negative patients did not significantly differ regarding age and sex. In
univariate analysis the presence of HCVAb was associated with an
increasing number of previous blood transfusions (P = 0.001), a longer
time on chronic hemodialysis (P 0.001), and higher serum ALT levels
(P 0.0001). In multivariate analysis the number of previous blood
transfusions (OR = 5, comparing none to 10 or more transfusions) and
time on dialysis (OR 12, comparing less than 3 to 9 or more years)
were the only independent risk factors identified. Conclusion: Mter
adjusting for the effects of other variables, time on dialysis is the most
important risk factor for HCV infection in this population.
Sepsis related to the use of catheters as temporary angioaccess in
hemodialysis patients. C. AlmeIda, I. Baldala, J.P. Olive ira, J.T.
Guinardes, L. Guerra, Servico de Nefrologia e Laboratório de Micro-
biologia, Hospital São João, Porto, Portugal. Infections are the most
frequent complications of using central catheters (C) as temporary
angioaccess (TA) for hemodialysis (HD). The most serious of these
complications is catheter related sepsis (CRS), whose incidence and
microbiological characteristics were studied in our department. Meth-
ods: The prospective study included all C inserted as TA for HD during
the second semester of 1992 (total = 182). Six C were excluded because
of insufficient information. The 176 C included in the study were
inserted in 135 patients (P) (sex: M = 78/F = 57; position: subclavian =
106/femoral = 58/jugular = 12; diagnosis: CRF l05/ARF = 28/acute
poisoning 2; total of 6143 days in situ). All hyperpiretic (H) episodes
suspected of CRS were analyzed. CRS was defined as H with the same
bacterium isolated from blood culture (BC) and culture of catheter (CC)
or, when CC was not obtained, H with positive BC, without any other
apparent infectious focus. Results and conclusions: 21 episodes of H
were registered in 19 P (sex: M = 15/F 4), after an average time in situ
of 29 days (range: 7—135). 18 episodes (in 16 F) occurred in the absence
of any other apparent infectious focus: in 16 of these BC were obtained,
13 of which were positive [Staph. aureus (SA) = 12]; in 14, CC were
simultaneously obtained, all of which were positive (SA = 11); in 10,
the isolate was the same in BC and CC (SA = 9); in 2, BC were positive(SA = 2) but CC were not obtained; in 3, BC were negative and CC
were positive, with purulent discharge being noted through the exit site
in 2 (SA = 2); in I, different bacteria were identified in BC and CC. In
2, excluded from the following calculations, neither BC nor CC were
performed. In the 3 cases in which there were other apparent infectious
focus, BC were positive in 2, both with different isolates in CC; in the
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remaining case, BC and CC were both negative. The 12 CRS episodes
(6.8% of all C, approximate incidence 1:475 days at risk) occurred after
an average time of 32 days in situ; 50% occurred during the first 2 weeks
after insertion, and SA was the isolated bacterium in 91.6% of cases.
Evolution of lymphocyte subsets (LSS) in the early renal transplant
(Trx) period. M.M. Guerra, A.M. Praca, J. Baldaia, J. Candeias, J.
Fernandes, and L.E. Guerra, Servico de Nefrologia e Servico de
Imunologia, Fac. Medicina-Universidade do Porto-Hospital de S.
João, Porto, Portugal. It is generally accepted that the changes in the
LSS in the peripheral blood do not accurately reflect what is happening
in the renal allograft. This lack of correlation, plus the need to define a
normal pattern of variation of these subsets in the transplant patient
(Trx pts) under routine immunosuppression (IS), led us to study the
evolution of several LSS in 19 cadaver kidney Trx pts free of any
episode of rejection, infection that didn't receive ATG or OKT3 and
had normal renal function. IS consisted of methyl-PND (1 mg/kg
tapering to 0.25 mg/kg at 15 days), AZA (2 mg/kg for 15 days and then
1 mg/kg), and CsA (10 mg/kg and then according to trough levels).
Determinations of the absolute number of the LSS were done: before
pre-Trx HD, after HD, 4 to 6 hours after Is, 12 hours after IS, on days
2, 4, 6, 8, 15, 30 and 90 after Trx. The samples were studied by
whole-blood flow-cytometry. The populations studied were: CD22 (B
cell subsets); CD3, CD4, CD8 (T cell subsets); CD57 (NK cells), CD29,
CD4CD29 (lymphocytes with adhesion molecules) and cells expressing
HLA-DR. We found that in all populations studied there was an initial
and significant decrease in cell number, related to the beginning of IS.
After that the populations showed a different behavior: while the CD3,
CD4, CD8, CD8CD1 ib-, CD4CD29, CD29 and DR showed a significant
increase at 3 months (P <0.05). There was no significant change in the
NK cells (CD57). The B cell subsets CD22 and CD22DR showed no
significant change. These LSS were the only ones that at 3 months
showed a significantly lower value (P <0.10) when compared with the
period before IS. These different patterns of evolution are difficult to
explain in view of the interplay of multiple factors, of which different
responses to IS and return of renal function to normal are probably very
important, and deserve further study.
CD4S isoforms In the early post-transplant (Trx) period. M.M. Guerra,
A.M. Praca, J. Baldaia, J. Candeias, J. Fernandes, and L.E. Guerra,
Servico de Nefro/ogia e Servico de Imunologia, Fac. Medicina, Uni-
versidade do Porto, Hospital de S. João, Porto, Portugal. Recently the
hypothesis that there is a synergy between "naive" and "memory" T
cells has been raised. This mechanism may be particularly important in
the process of allograft rejection. The role of cytokines, particularly
IL-2, IL-4 and IL-6 has been stressed. We studied the evolution of the
T cell subsets (TCS) CD45RA and CD45RO in 22 kidney Trx patients
free of any episodes of rejection, infection, and who didn't receive ATG
or OKT3. Immunosuppression (IS) consisted of methyl-PND (1 mg/kg
tapering to 0.25 mg/kg at 15 days), AZA (2 mg/kg for 15 days and then
1 mg/kg), and CsA according to trough levels. Determinations of TCS
were done: before pre-Trx HD, after HD, 4 to 6 hours after IS, 12 hours
after IS, on days 2, 4, 6, 8, 15, 30 and 90 after Trx. The samples were
studied by whole-blood flow-cytometry.
CD45RA CD45RO
Before HD 648 343 (18) 329 262 (18)
After HD 872 510 (20) 464 507 (20)
Is 538 253 (21) 242 214 (21)
12 Hours 309 216 (19) 104 75 (19)
2 Days 350 416 (19) 143 150 (19)
4 Days 373 197 (20) 169 124 (20)
6 Days 509 341 (13) 245 155 (13)
8 Days 713 440 (17) 554 795 (17)
15 Days 666 467 (15) 464 311 (17)
1 Month 553 349 (15) 241 218 (15)
3 Months 858 396 (9) 328 240 (9)
a Average SD (N).
We found that, after a profound initial depression of both TCS, followed
by a rebound at 15 days, the absolute number rose gradually above the
IS level, for the CD45RA (P < 0.05), while there was no significant
increase for the CD45RO. Its possible that this depression may repre-
sent inhibition of IL-2 synthesis by CsA with subsequent blocking of the
synergy between naive and memory T cells. If so, the analysis of this 2
TCS may be a useful way of monitoring IS therapy.
Analysis of intra- and interdialysis symptoms in acetate versus bicar-
bonate dialysis. J.C. Barreto, A. Santana, A. Gaspar, N. Bigotte, L.
Carvalho, L. Leitão, J.M. Boquinhas, and Jacinto SimOes, N.M.C.,
Restelo; ClInica Médica e Diagnóstico Dr. Joaquim Chaves, Hospital
de Santa Cruz, Lisboa, Portugal. Objectives: To compare the symp-
tomatology of patients submitted to acetate (AC) versus bicarbonate
(Bic) hemodialysis (HD) with different sodium (Na) concentrations.
Patients and methods: 20 patients (15 F and 5 M) with chronic renal
failure (CRF) on HD for X = 67 51 months and with the mean age of
60 15 years, were submitted to 4 dialysis sessions:
2 sessions with AC:
Group A with Na = 136 mEq/liter
Group B with Na = 144 mEq/liter
2 sessions with Bic:
Group C with Na = 136 mEq/liter
Group D with Na = 144 mEq/liter
During the dialysis non-reusable capillary filters of cuprophane were
employed. The percentage of weight lost was < 5%. The intra- and
interdialytic symptoms were recorded; the arterial pressure (AP) and
pulse registered hourly; the Na and potassium (K) concentrations were
determined along with the blood gases from the A-V fistula, osmolarity
and acetate (Groups A and B); all through out the different HD sessions.
Results: (1) On average, the AP dropped during HD in Groups A and B,
having been significant at the second hour (P = 0.006) and after HD (P
= 0.000). In Groups C and D, the difference was significant only at the
second hour (P = 0.05). The number of hypotensive episodes was
similar in the Groups using different HD methods (AC vs. Bic), but
there were fewer symptomatic episodes in the dialysis with an Na
concentration of 144 mEq/liter. (2) The heart rate increased in all
Groups (P = 0.000), except in Group D (P = N5). (3) In the Bic Groups,
no cases of nausea, vomiting (P = 0.01), headaches or angina were
recorded. Cramps were more frequent in the Bic Groups, especially in
the HD sessions with the lowest Na concentration. (4) After the
sessions, the patients submitted to a Na = 144 mEq/liter complainted of
thirst, whereas those submitted to a Na = 136 mEq/liter complainted of
cramps. (5) After dialysis, it took the patients in the AC Groups, on
average, 11.3 8.3 hours to recuperate their sense of well-being, as
opposed to 4.4 4.8 hours for patients in the Bic Groups (P = 0.006).(6) In all groups, there was a correction of acidosis, the serum Na
concentration remained stable, and there was a decrease in urea and K
concentrations and in the osmolarity (P = NS). There was no relation
between Acetate levels and intradialytic symptoms. Conclusions: In the
patients studied, there was greater hemodynamic stability during the
HD sessions, as well as a greater sense of well-being after the sessions
in the Bic Groups. Hypotention and cramps seemed to be more
dependent upon the Na concentration.
Helicobacter Pylon infection in chronic renal failure patients on a
regular hemodialysis program. J. Car/os Barreto, M. Silva, L. Lebre,
A.P. Martins, and J. SimOes, Hospital de Santa Cruz, Lisboa, Portu-
gal. It is currently accepted that Helicobacter Pylon (HP) infection is
the most common and most important cause of gastritis and has been
linked to peptic ulcer, non-ulcerous dispepsia, and gastric cancer.
Given the importance of the gastro-duodenal disease in chronic renal
failure patients and the metabolic properties of HP (breakdown of urea
into ammonia), we analyzed the prevalence of infection in a group of 20
chronic renal failure patients kept on a regular hemodialysis program
(10 males, 10 females), with a mean age of 56.5 years and an average
time on hemodialysis of 44 months. All patients underwent upper
gastrointestinal endoscopy and HP was systematically searched for by
means of antral biopsy and urease test (Clo-Test®). Of the 20 patients
involved in the study, 17 had previous complaints of dyspepsia and/or
gastro-duodenal disease, as confirmed by upper gastrointestinal endos-
copy. The presence of infection was confirmed in 11 patients (55%). All
those positive for HP exhibited alterations in the gastric and/or duode-
nal mucosae. Unexpectedly, considering the high urea (BUN) concen-
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trations in these patients, the prevalence of infection was not significantly
higher than that seen in non-renal failure patients of the same age group,
24-hour blood pressure monitoring in an ambulatory setting. J. Miguel
Boquinhas, J. Carlos Barreto, A. Gaspar, M.H. Boquinhas, and J.
Simdes, Hospital Santa Cruz, Lisboa, Portugal. Material and methods:
The blood pressure (BP) of 35 patients, 27 of whom were males and 8
were females, was controlled for a 24-hour period in an ambulatory
setting. The mean age of the subjects was 51 14 years. The indications
for the study were the following: 12 for suspected resistant hyperten-
sion, 11 for suspected "white coat" hypertension, 7 who were to
undergo a readjustment of therapy, 3 with episodes suggestive of
hypotensive crises, 1 with borderline hypertension and, finally, 1 with
suspected pheocromocitoma. The percentage >40% of hypertensive
peaks, both systolic and diastolic, was registered during the day (syst>
140mm Hg; diast > 90mm Hg) and night (sys >120mm Hg; diast >80
minHg). Furthermore, we studied the possible absence of correlation
between the mean BP as measured randomly and the mean BP during
the 24-hour period. Results: In 43% of these patients, the study did not
confirm the proposed indication. The number of patients with a per-
centage of hypertensive peaks >40% during the day were: systolic N =
1; diastolic N 4; systolic and diastolic N = 20. During the night, the
peaks were: systolic N = 6; diastolic N = 1; systolic and diastolic N =
13. A statistically significant correlation was shown between the mean
BP as measured randomly and the mean BP during the 24-hour period(r = 0.537 and P 0.002). Conclusion: (1) Registering BP in an
ambulatory setting is a good method for the correct diagnosis of certain
situations, especially when there is suspicion of resistant, borderline
and "office hypertension," as well as for the readjustment of antihy-
pertensive therapy. (2) The study allowed for therapeutic adjustments
in patients in whom that need was demonstrated (N = 9). (3) There was
a statistically significant correlation between the mean BP as measured
randomly and the mean BP as measured during a 24-hour period.
ARF: Experience of one Hospital Central. H. Oliveira, F. Macdrio, A.
Patrfcio, H. Gomes, M. Campos, and A. Marques, Servico de Nefro-
logia dos H. U.C., Coimbra, Portugal. We prospectively studied 103
cases of acute renal failure (ARF) that were followed by the Nephrology
Department at Hospital da Universidade de Coimbra, for the period
between November 1991 until October 1992. The population analyzed
had an average age of 62.81 18.84 years, and males predominated
(62.14%). A mortality rate of 34.95% (36 patients) was observed and a
statistically significant relation to urinary output and underlying dis-
eases was assessed. Eighty-eight patients (85.4%) were threatened by
metabolic, cardiovascular, hematologic, neurologic, gastrointestinal,
and/or infectious complications during their hospital stay. Forty-seven
patients required renal replacement therapy: forty-three patients(41.7%) were subjected to hemodialysis with an average number of
sessions of 7.9 7.69, while in four (3.88%) continuous hemofiltration
was employed. The former group had a mortality rate of 51.16% and in
the latter group only one patient survived hospital discharge. Mortality
was statistically significantly higher in surgical departments and inten-
sive care units than in departments of medicine (P = 0.01). Death was
related to underlying disease in 50% of cases, while ARF complications
killed 38.9% of patients, and 11.1% died with multiple organ failure.
Survivors were discharged after an average period of 21 days of
hospitalization with a serum creatinine of 1.37 + 0.92 mg/dl. Only 3
patients (2.9%) did not recover independent renal function, requiring
long-term renal replacement therapy.
Utility of skin biopsy and fine-needle aspiration of subcutaneous fat in
nephropathology diagnosis. F. Carvalho, M.J, Amaro, M.J. Guerreiro,
and A.M. Costa, LaboratOrio de Moifologia Renal, Seri'ico de Nefro-
logia, Hospital de Curry Cabral, Lisboa, Portugal. In the last years,
skin biopsy (SB) and fine-needle aspiration of subcutaneous fat (FNAF)
have been confirmed as good methods for identifying patients (P) with
systemic lupus (SL) and amyloidosis (A). SB was studied by immuno-
fluorescence (IMF), demonstrating immunoglobulin (Ig) deposits and
complement (C) factors at dermal-epidermal junction (DIE), which is
highly suggestive of SL. In a published study we demonstrated that this
method has a high specificity (SP) and sensitivity (SI) (85.8%, 87%) in
the diagnosis of SL, 1gM being the Ig most often found. The test is
positive in P subjected to a long corticosteroid therapy, and in some
varieties of SL not complying the ARA criteria. FNAF studied by light
microscopy is the principal method for identifying A, especially in those
p who cannot undergo a renal biopsy (RB). Our results revealed very
high SP and ST, respectively 100% and 83%. We proposed that FNAF
should be done to all P older than forty years, with unexplained
proteinuria or nephrotic syndrome. In the last 3 years we diagnosed 6 P
with light-chain deposition disease (LCDD), in 3 P we performed SB
and FNAF. IMF revealed deposits of A light-chain along DIE and in
dermal vessels, as in the subcutaneous fat, according with RB. In 4
cases of A, 2 primary (Pr) and 2 secondary (Sc), confirmed by RB it was
possible by FNAF studied by IMF, to identify the nature of amyloid
substance (AS) deposited in fat. At 2 Pr deposits were A light chains and
at 2 Sc deposits were AA. In 15 P with Portuguese type amyloidosis
(PTA), FNAF was positive for all. The nature of AS couldn't be proved
to be transthyretin because specific antiserum was not available. In 8
cases of carpal tunnel syndrome in hemodialysis patients, FNAF was
systematically negative. Conclusions: SB and FNAF proved to be
useful, simple and safe tests for the SL and A diagnosis. The immuno-
pathologic findings suggest that FNAF can be a valuable method for the
identification of P with LCDD and for the characterization of AS in A.
Carpal tunnel syndrome (CTS) in hensodialysis patients: A preliminary
clInical-morphologic study. F. Carvaiho, P. Felicissimo, A. Vila Lobos,
A. Coelho, andA.M. Costa, Laboratório de Motfologia Renal, Servico
de Nefrologia, Hospital de Curry Cabral, Lisboa, Portugal. Dialysis
amyloidosis is characterized by f32-microglobulin (2m) fibrillar deposi-
tion in different body structures. Carpal tunnel (CT) is frequently
evolved. Its technical accessibility allows the obtentaing of material
that, upon being examined, allows for a better knowledge of this serious
complication of long-term dialysis. From 1989 to 1993 we obtained CT
specimens (S) from 19 patients (P) subjected to hemodialysis (H) with
standard cellulosic membranes. Eight S were obtained in our depart-
ment and different CT structures were intersected (subcutaneous fat,
median nerve, tendon and ligament synovium). These were processed
for light microscopy (LM), immunofluorescence microscopy (IMF) and
electron-microscopy (EM) study. Subcutaneous abdominal fat (SAF)
was also obtained. Eleven S sent to us by other departments were only
processed for LM and IMF. Ten out of 19 S were positive to 132m, 6
being from our department. /32m deposition was more frequently
observed in the tendon synovium, most of the times weakly staining.
Clinical data were obtained from 15 P; 10 P were female, the mean age
and mean dialysis time were respectively 58.6 13.4years and 124.5
30.9 months. In 7 out of 12 P with typical CTS symptoms f3m was
positive. No symptomatic relief was obtained in 2 P, I showing serious
median nerve compression. In 3 P with doubtful symptoms /32m was
negative and there was no symptomatic relief. In 7 P (5 with f32m at CT)
bone alterations were observed that suggested amyloid involvement at
other joints: cervical column, shoulder, and wrist. In 8 P an SAF search
for amyloid was negative. Staining with other antiserums (AA, K, A,
prealbumin) was systematically negative, Cellular infiltrate was, in most
of the cases, scanty and non-inflammatory. Conclusions: 53% of 19 CTS
P were /32m positive; positivity increased at specimens including
synovium of different CT structures. Tendon synovium was the most
positive tissue. 47% of the P were f32m negative; this fact, associated
with the finding of weak staining of f32m in most synovium, supports the
possibility that other factors may contribute to the development of
CTS.
Subcutaneous erythropoietin/intravenous erythropoietin efficacy study
in hemodialysis patients. F. Carvaiho, F. Remédio, A. Vila Lobos, A.
Ramos, F. Calado, and F. Ribeiro, ClInica de Doencas Renais, Lisboa,
Portugal. Erythropoietin (Epo) is currently the principal therapy for
anemia in dialysis patients. Search for a better cost/efficacy relationship
has determined in favor of subcutaneous (s.c.) rather than intravenous
(i,v.) administration. For evaluation of this practice we studied during 6
months 23 patients (P) divided into 2 groups (G) of s.c. administration
(SG and TG). P with infections and neoplastic diseases, hypertension
and on iron therapy were excluded from the study. SG consisted of 11
P that were never treated with Epo and initiated treatment with s.c.
Epo, Six F were male, the mean age and the mean dialysis time were
respectively 49.4 years and 4 months. TG included 12 P that changed
from i.v. to s.c. administration. Six P were male, the mean age and the
mean dialysis time were 62.8 years and 46 months. A control group
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(CG) of 12 P was considered, treated with i.v. Epo. Seven P were male,
the mean age and the mean dialysis time were 55.4 years and 61 months.
s.c. Epo was administrated to SG twice a week (W), at the deltoid area,
5 minutes before hemodialysis (HD). In the beginning of the study mean
s.c. Epo doses were: SG = 71.4 U/kg body wt; TG = 61.3 U/kg body
wt. (i.v. Epo prior to s.c. Epo transition was 116.3 U/kg body wt). At
CG initial i.v. Epo dose was 149.1 U/kg body wt. We compared Epo
mean dose and hemoglobin (Hb) mean value at the beginning of the
Study (0) and after 6 months (6); we noticed a little increment in E doses
at SG and TG during the study: SGO = 71.4 U/kg body wt ' SG6 =
70.0 U/kg body wt and TOO = 61.3 U/kg body wt TG6 = 73.8 U/kg
body wt. At CO i.v. Epo dose was lowered from 149.1 U/kg body wt '
128.3 U/kg body wt. Differences in the mean final dose of s.c. Epo at SO
and TO, when compared with mean final doses of i.v. Epo at CG, and
decreasing of the Epo dose at TO, between the end of i.v. Epo and at
the end of s.c. Epo, were significant. Important increases in the mean
value of Hb at SO were noticed: HbO = 7.7 g/dl Hb6 = 10.0g/dl. At
TO, Hb was stable at s.c. period: HbO 11.0 g/dl ' Hb6 = 10.4g/dl.
We concluded that s.c. Epo in anemia therapy of dialysis P attained the
same efficacy as that of i.v. Epo using significantly lower doses.
Light-chain deposition disease (LCDD): Immunopathologic (IP) aspects
of renal Involvement in 6 cases. F. Carvaiho, T. Mendes, I. Pratas, and
A.M. Costa, LaboratOrio de Morfologia Renal, Servico de Nefrologia,
Hospital de Curry Cabral, Centro Hospitalar de Coimbra, Hospital
Universitdrio de Coimbra, Lisboa, Portugal. LCDD was described by
Randall in 1976. It is a serious systemic disease with a preponderant
renal involvement. Immunoelectrophoresis (IF) is a sensitive method to
detect light chains (LCs) in serum (5) and urine (U), and renal biopsy
(RB) examined by routine immunofluorescence microscopy (IMF)
detects the LC deposit in the kidney. In the present report we describe
the clinical and IP aspects of 6 patients (P) diagnosed in our department
in the last 3 years. The mean age was 63 years-old, with an equal sex
distribution. Proteinuria (Pr) and renal failure (RF) were the main
presenting features. The degree of Pr was variable and in 4 P, Pr was>
3 g per 24 hours. The mean serum creatinine (Scr) was 2.7 mg/dl. All P
had moderate arterial hypertension preceding renal disease for a long
time; 2 P presented serious congestive heart failure with relapsing right
pleural effusion. By IF, LCs in S and U were demonstrated: 3 kappa
and 3 lambda. 4 P had bone marrow plasmocytosis > to 15% and the
remaining 2 P had normal numbers of plasma cells; only in one P
cytologic was evidence of myeloma was demonstrated. In 5 bony
skeleton was observed; no lytic lesions were detected. The IP aspects
on RB studied by IMF were very characteristic, consisting of a linear
fixation of the LC antisera along all tubular and some glomerular
basement membranes (BM). By light microscopy we observed nodular
glomerulosclerosis with capillary aneurysme in 2 P, and in the other 4 P,
moderate enlargement of the mesangium with thickening of the glomer-
ular capillary walls. In 3 P tubular lesions were characterized by a bright
ribbon-like thickening of the tubular BM; 1 P had prominent Bence-
Jones casts. The extrarenal involvement was demonstrated in 1 P with
LC deposits in pleura, skin, and abdominal subcutaneous fat. On the
follow-up, 2 P died and two were on regular dialysis 12 months after the
diagnosis; the other two have mean Se,. 3 mg/dl, 4 months after
diagnosis. Conclusions: a high level of clinical suspicion is necessary in
a patient with unexplained Pr and RF; the S and U IF are very
important for the diagnosis which can be confirmed by the demonstra-
tion of LC deposit on RB.
Intravenous iron in anemia treatment of hemodialysis patients. A. Vila
Lobos, F. Remédio, I. Calado, A. Ra,nos, F. Carvalho, and F. Ribeiro,
Cilnica de Doencas Renais, Lisboa, Portugal. After the introduction of
recombinant human erythropoietin (rHuEPO) as the principal therapy
of anemia of dialysis patients, iron deficiency has become the main
factor of failure in its correction. Using intravenous (i.v.) iron we can
quickly correct anemia and overcome the frequent problem of oral iron
intolerance. We retrospectively assessed the effect of intravenous
hydroxide iron in the anemia of 18 hemodialysis patients. Twelve
patients were women, the mean age and the mean dialysis time were,
respectively, 50.9 16.7 years and 56.0 39.7 months. None of the
patients had folate and/or B12 deficiency. Patients treated with desfer-
oxamine, receiving blood transfusions or having bleeding in the previ-
ous 6 months or during the i.v. treatment, were excluded from the
study. Fourteen patients were on EPO therapy without significant
variation in their doses from the previous 6 months or while under i.v.
iron administration. The mean value of serum ferritin (Ferrit) before the
i.v. medication (on mean dose of oral iron sulfate of 2100 mg week) was
58.0 45.9 ng/ml. Other hematological parameters: hemoglobin (Hb),
hematocrit (Htc), and serum iron (Ir) were stabilized and their mean
values were, respectively, 9.43 1.12mg/dl, 28.03 3.54% and 63.20
16.14 sg/dl. i.v. iron was given in a mean dose of 100mg weekly. We
divided our population in groups (0) considering cumulative doses of
i.v. iron: 010.4 g, N = 18; OIl 0.8 g, N = 16; 01111.2 g, N = 15; OIV
1.6g;N= 11;OV2.Og,N=8;GVI2.4g,N=8;OVII2.8g,N=6;GVIII 3.2 g, N = 4 patients. During i.v. iron administration, we
compared in each group of patients the mean values of Hb, Htc and Ir
with the mean values of the same hematological parameters in the
preceding 6 months of the same patients. We noticed a small increase in
Hb, Htc and Ir, only with statistical significance for Hb (P = 0.035)
when the cumulative dose of 1.2 g was reached; with further stabiliza-
tion of those parameters despite increases in the dose of i.v. iron. The
mean increment for all patients after i.v. iron was: Hb = 0.81 g/dl, Htc
= 2.05% and Ir = 7.28 ug/dl. As we anticipated, Ferrit increased
significantly during our study. We conclude that: (1) serum iron is not a
reliable parameter to assess i.v. iron therapy. (2) i.v. iron has not
significantly modified hematological parameters of anemia. (3) Oiven
the risk of iron overload, i.v. iron should not be administered in doses
greater than 1.2 g.
Importance of fractional shortening In cardiac function evaluation in
chronic hemodialysis patients. Q. Rato, E. Pedroso, J. Vinhas, A.
Ramos, A. Fernandes, andA. Forjaz, Hospital São Bernardo, Setdbal,
Portugal. Fractional shortening (FS) has been frequently used for left
ventricular function evaluation. However, in chronic hemodialysis
patients the presence of anemia, arteriovenous shunting, rapid volemia
variations, abnormalities of acid base and electrolyte metabolism can
modify its sensibility and specificity. For testing this hypothesis we
studied 10 patients in the chronic hemodialysis program. An experi-
enced cardiologist performed both M-mode and two-dimensional
echocardiographic studies in all patients. The echocardiographic mea-
surements, obtained pre-dialysis, included left ventricular end-diastolic
and end-systolic diameters measured before and after one minute of
clamping the arteriovenous fistula. Additionally, all patients underwent
exercise stress testing on a treadmill. The Bruce Protocol was used 24
hours after hemodialysis. All patients had hemoglobin > 9 g/dl. With
clamping we met a reduction in the end-diastolic diameter, however,
with no statistic significance (5.34 to 5.26 cm; P NS). The FS didn't
change (37.4% to 37.9%; P = NS). We couldn't find any correlation in
the cardiac performance evaluated by exercise stress testing and FS.
We conclude that FS isn't a good parameter for cardiac function
evaluation in chronic hemodialysis patients.
Determinants of left ventricular hypertrophy in hemodlalysis patients.
Q. Rato, E. Pedroso, J. Vinhas, A. Ramos, A. Fernandes, and A.
Forjaz, Hospital de São Bernardo, Setübal, Portugal. Left ventricular
hypertrophy (LVH) represents an independent factor of cardiovascular
risk and its prevalence in patients with end-stage renal disease appears
to be higher than in the general population. This study was designed to
evaluate the determinants of LVH in a population with end-stage renal
disease treated by hemodialysis. Of 102 patients in the hemodialysis
program during the study period, we selected 31 that had two or more
echocardiographic studies separated by at least 6 months (median: 19.7
months). We studied the impact of some factors that may contribute to
left ventricular mass index (LVMI) evolution, such as: arterial pres-
sure, anti-hypertensive therapy, weight gain between dialysis, erythro-
poietin therapy, hemoglobin, and parathyroid hormone levels. These 31
patients were divided into two groups: group 1 (N = 13) that showed an
increase of LVMI (110.2 32.9 g/m2 to 195.6 g/m2) between the
echocardiographic studies referred to above; and group 2 (N = 18)
without variation of LYMI during the same study period. At the same
time we selected and studied a control group (N = 15) to establish the
normality of LVMI limits. We found it not possible to correlate the
increase in LVMI in group 1 to any of the factors studied.
Proliferation of cells obtained by FNAB at 7 and 30 days post-kidney
transplant. G. Oliveira, P. Xavier, A. Mendes, and L. Guerra, Servico
de Nefrologia, Hospital S. João, Porto, Portugal. We measured the
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proliferation of cells obtained by fine needle aspiration biopsies (FNAB)
of kidney transplants during the first month post-Tx. Eight patients on
regular HD for 9 to 24 months received a first cadaver kidney Tx,
treated with triple therapy. FNAB was done at 7 and 30 days and the
cell culture was supplemented with IL-2 at 20 U/mI. At 7 days two
patients were HD dependent, one had creatinine 9.0 mg/dI and the other
6 had creatinine less than 2.5 mg/dl; cell count was 7674 1876 cpni,
and at 30 days one was still HD dependent, one had CMV disease, one
had an unspecified renal disease transmitted with the Tx (creatinine 8.0
mg/dl), one was minus 2 days to first rejection, and the five others had
good graft function; cell count was 603 198 cpm; paired Student's
t-test 0.006. Conclusion: proliferation of cells from FNAB was signifi-
cantly greater at 7 days than at 30 days post-Tx in a small group of
patients free of rejection during the first month of kidney Tx.
Is pre-dialytic, post-dIalytic or mean interdlalytic blood pressure ade-
quate for BP control? M.S. Faria, J. Ferraz, G. Oliveira, J.P. Nunes, J.
Polônia, and L. Guerra, Servicos Nefrologia e Medicina 3, Hospital
São Jodo, Porto, Portugal. Our aim was to determine whether predi-
alysis (PRE), post-dialysis (POS), 2-hour intradialytic (2H) or 20-hour
post-dialysis (20H) blood pressure measurement is the most represen-
tative value of the average blood pressure (AVBP) in clinically stable
hemodialysis (HD) patients. Ten patients, aged 44.5 12.5 years (4
males and 6 females), with chronic renal failure, undergoing HD for at
least 3 months, three times weekly (4 hours each session) were studied,
using the Spacelabs model 90207 for 48 hours, starting 1 hour before the
beginning of HD. An average value of 133.6 16.0 blood pressure
measurements was obtained for each patient. Their residual urea
clearance was inferior to 2.5 mI/mm. Both PRE (159.6 28.9/99.0
17.4 mm Hg) and POS (153.0 27.8/95.4 15.5) values were found to
be significantly higher than AVBP (142.1 18.9/86.5 11.0) (P = 0.05,
paired t-test). 2H (143.8 23.5/86.4 14.6) values were not signifi-
cantly different from AVBP. Neither PRE nor POS values provide
adequate estimates of AVBP. Both 2H and 20H values seem to be
better options when estimating AVBP in HD patients. As either
undertreatment or overtreatment of hypertension might be harmful for
HD patients, ambulatory blood pressure monitoring studies seem
worthwhile in patients.
lily infection after kidney transplantation: Report of two cases. M.J.
Mariano, N. ZOzimo, J. Guerra, J. Lopes, F. Rego, M.J. Sampaio,
A.M. Correia, J.R. Pena, and A. Gomes da Costa, UTR do Hospital da
Cruz Vermelha Portuguesa, Lisboa, Portugal. We report two patients
who were infected with HIV after cadaver kidney transplantation.
DMLM—A 30 year-old male patient with chronic renal failure second-
ary to crescentic glomenilonephritis. He started hemodialysis in May
1984, and he was grafted in March 1989. He was immunosuppressed
with cyclosporine and prednisolone. Post-transplant evolution was
eventless. In July 1989 he had asymptomatic CMV reactivation, and in
September 1989 Kaposi sarcoma was diagnosed. Cyclosporine was
step-wise reduced and azathioprine started. In October, he had lasting
profuse diarrhea with abdominal scan and jejunal biopsy without
abnormalities; HIV I and II were negative. In November 1989 cyclo-
sporine was stopped and Kaposy sarcoma was in remission. He
remained stabilized until November 1990 when he had granuloma
venereum and lost 10 kg weight. In April 1991 he had fatigue, anorexia,
nausea and epigastric burn. Esophagic endoscopy showed esophagitis
and HIV I was positive. In May 1991 he had a pulmonary infection with
pneumocystis carinii and CMV. He died on the 5/19/1991 with normal
renal function. MLS—a 30-year-old male patient with chronic renal
failure secondary to Alport Syndrome. He started hemodialysis in
January 1986 and was grafted in January 1988. He was immunosup-
pressed with cyclosporine and prednisolone and was HIV I and II
negative. His evolution after transplantation was eventless besides a
granuloma venereum, and in April 1989 was treated with cotrimoxazol.
In March 1992 in routine tests he was found to be HIV I positive and
remains symptom-free to the present day.
Cyciosporine pharmacokinetics in patients on waiting lists for kidney
transplantation..A,C. Nogueira, J.G. Silva, E. Almeida, J. Guerra, A.
Gomes da Costa, J.M. Vale, M.E. Araujo Pereira, M.M. Prata, and F.
Paredes, U. Nefrologia, Servico Farmácia e Serviço de Patologia,
Hospital de Santa Maria, Lisboa, Portugal. The wide range of individ-
ual cyclosporine pharmacokinetics makes its use difficult in clinical
practice. This reason prompted us to start a study of pharmacokinetics
profile in patients on waiting lists for kidney graft. Patients were
selected through criteria of immunological risk (Dr6, hyperimmunized
or second grafts), or risks of changes of absortion related to gastric
hypomotility (diabetics). The study was performed with hourly deter-
minations of cyclosporine whole blood levels after i.v. administration of
3 mg/kg body wt and oral administration of 15 mg/kg body wt. With
these values were calculated the clearance (Cl), distribution volume
(Vd), half-life (t-1/2), elimination constant (Ke), absorbtion constant
(Ka), and biodisponibility (F%). With these parameters the individual
dose to be prescribed when the patients were transplanted was calcu-
lated. Sixteen patients were studied and their parameters were:
Mean DP Extremes
Cl (I/h) 31.46 14.48 19.3/77.7
Vd(l/kg) 2.23 1.12 0.84/4.6
t-1/2(h) 2.96 0.99 1.5/5.7
Ke (h-I) 0.26 0.09 0.12/0.47
Ka (h-I) 0.46 1.09 0.07/4.5
F(%) 25.55 10.85 12/52
Dose i.v. 5.1 2.47 1.8/11.2
Dose oral 20.5 7.28 11.5/30
Occlusion of the subciavian veins after catheterization for hemodlalysis.
J. QueirOs, A. Cabrita, J. Tavares, R. Castro, 1. Maximino, M. Silva,
M. Pereira, and E. Xavier, Servico de Nefrologia, Hospital Santo
AntOnio, Porto, Portugal. Stenosis of the subclavian veins is a terrible
complication in hemodialysis patients considering the development of
venous hypertension syndromes, when an arteriovenous fistula is
placed distally to the stenosis. This complication is frequently asymp-
tomatic. The aim of our study was the evaluation of the subclavian vein
stenosis rate and its possible risk factors. We performed a venous
angiography in 26 asymptomatic patients who had a single catheter
during the last year. The patients had a mean age of 55.9 18.8 years
and 14 (54%) were males.
Phiebography
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14
16.0 52.9 20.4
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NS"
Acute renal failure 0 7 <0.05"
Cannulation time days 38.4 20.2 31.0 23.0 NSU
Erythropoietin
Septicemia
8
0
6
4
NSb
NSb
Local infection 2 4 NS"
Obstruction 1 2 NSb
Punctures> 1 6 6 NSb
a t-test; b k.2
Conclusions: (1) The incidence of subclavian vein stenosis after cathe-
terization for hemodialysis is very high and frequently asymptomatic.
(2) Acute renal failure patients seem protected from this complication.
A rare cause of macroscopic hematuna after renal biopsy. J. Queiros,
I. Silva, L. Lobato, C. Mota, A. Norton, M. Pereira, and E. Xavier,
Servico de Nefrologia e Cardiovascular, Hospital Santo AntOnio,
Porto, Portugal. We describe a rare complication of percutaneous renal
biopsy using the Franklin modification of the Vim Silverman needle. A
72 year-old man was admitted for acute renal failure of unknown
etiology requiring hemodialysis. A renal biopsy under ecographic
control was done in the left kidney without immediate complications.
Histologic examination show a generalized and diffuse endocapillary
proliferative exudative glomerulonephritis. He maintained oliguric, and
16 days after the biopsy he developed a severe persistent hematuria
requiring several blood transfusions. A cystoscopic examination local-
ized hematuria to the left side. A renal arteriogram revealed bilateral
intrarenal aneurysms. Since hematuna persisted during several days, a
selective embolization of the two inferior left aneurysms using SPON-
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GOSTAN was performed under selective renal artery catheterization.
There were no immediate or late complications of the procedure, nor
did hematuria recur. No morphological alteration was found in poste-
rior ultrasonographic examination.
Nephropathy in the familial amyloidotic polyneuropathy (FAP) TTR
Met 30—Epidemlologlcal and clinical study. L. Lobato, A. Sousa, R.
Jorge, P.P. Costa, J. Azevedo, S. Caspurro, and E. Xavier, Servicos de
Nefrologia e Patologia, Hospital Santo Antonio; Instituto de Ciências
Biomédicas Abel Salazar; Centro de Estudos de Paramiloidose, Porto,
Portugal. Familial amyloidotic polyneuropathy Portuguese type (TTR
Met 30) is a systemic form of amyloidosis, inherited in an autosomal
dominant mode. Renal disease has been considered uncommon. This
feature distinguished that form of hereditary amyloidosis from others.
We recently described Portuguese FAP patients with nephrotic protein-
uria and chronic renal failure. The aim of this study was to evaluate
epidemiological and clinical characteristics of nephropathy. We studied
56 patients with proteinuria> 1 g/day or serum creatinine> 1.2 mg/dl.
We found 22 men and 34 women belonging to 49 pedigrees (M/F: 1/1.5
vs. 1.3/1 in all 1246 FAP patients); 9 in the 11 patients that later
underwent dialysis were women. In 17 cases neither parent had shown
symptoms of the disease (30.4% vs. 12.7% in all patients, P < 0.001).
Age of onset was significantly higher in our group than average (39.6
11.0 vs. 33.5 9.6 years; P < 0.001). In dialysis patients age of onset
was even higher (43.8 9.4 years). In our first observation the duration
of the disease was on average 7.4 3.8 years, proteinuria 3.5 3 g/day
(14—1 glday), serum creatinine 1.4 0.96mg/dl, serum urea 75.3 52.7
mg/dl, and mean blood pressure (MBP) 95.1 20.7 mm Hg. The
patients with nephrotic range proteinuria presented a higher blood
pressure: 100.2 20.5 mm Hg. In those who progressed to chronic
renal failure (CRF) the MBP was 105. 19.9 mm Hg. If the patients
with CRF had a clinical course with nephrotic proteinuria, the MBP was
109.7 21.9. In 38 patients we performed ultrasound imaging of the
kidney: 73% had normal size, 76% increased echogenicity, corticome-
dullary differentiation remained in 52%; hydronephrosis was present in
13%. We demonstrated the abnormal protein in the kidney by immu-
nostaining with monoclonal antibodies anti-TTR. Conclusions: CRF
seems more common in women. In 1/3 of our patients the parents were
disease-free. Age of onset was significantly later in the group with
nephropathy. MBP was higher in those who progressed to CRF with
nephrotic proteinuria. Ultrasound imaging showed normal renal size in
73% of the patients.
The effect of fish oil (FO) dietary supplement on renal function of
diabetic rats. G. Santoro-Lopes, A.F. Xavier, T. Carvaiho, L. Caldas,
and R. Bregman, Nefrologia, UERJ, Cilnica Médica C, UNI-RIO,
Patologia Geral, UFF, Rio de Janeiro, Brazil. Thromboxane A2 (TXA2)
has been implicated as a mediator of the progression of glomerular
disease in several models of renal disease. N-3 fatty acids have been
shown to reduce the synthesis of TXA2. Thus, diet supplement with FO
(which contains high concentrations of n-3 fatty acids) has been tried in
the treatment of different renal diseases. The results of such studies
have been controversial. We used FO diet supplement in Wistar rats
with diabetes mellitus (induced by streptozotocin). Renal function was
studied after 12 weeks in unanesthetized rats. Results:
MGV
Groups GFRb RPFb lO mm3 GSI
C 1.l4a 3.4 2.4 1.4
N = 8 0.08 0.2 0.1 0.4
DM 0.21 4.1 2.9 2.5
N = 8 0.10 0.4 0.3 0.8
FO 1.20 3.6 3.1 1.0
N = 7 0.05 0.4 0.3 0.4
DM-FO 0.97 3.1 2.7 3.3N 8 0.07 0.4 0.2 1.3
a x + b j1J/.j . g of kidney weight.
Abbreviations are: C, control; DM, diabetes mellitus; FO, fish oil;
GFR, glomerular filtration rate; RPF, renal plasma flow; MGV, mean
glomerular volume; GSI, glomerular sclerosis index.
The results in the DM-FO group, though not statistically significant,
showed a tendency to worsen GFR as well as GSI. Similar results were
found in 5/6 ablation of renal mass, another model of non-immunologic
renal injury.
The effect of unilateral nephrectomy on renal function of diabetic rats.
A study in unanesthetized animals. G. Santoro-Lopes, A.F. Xavier, T.
Carvalho, L. Caldas, and R. Bregman, Nefrologia, UERJ, Cilnica
Médica, UNI-RIO, Patologia Geral, UFF, Rio de Janeiro, Brazil.
Hyperfiltration and hypertrophy seem to be associated with the pro-
gression of renal disease. The association of unilateral nephrectomy
(Nx) and diabetes mellitus (DM) has been less studied as a model of
renal disease. We evaluated renal function in unanesthetized Wistar
rats with DM (induced by streptozotocin), 12 weeks after Nx (DM-Nx).
Glomerular sclerosis index (GSI) and mean glomerular volume (VGM)
were determined. Data were compared with control (C), non-nephrec-
tomized diabetic (DM) and Nx animals.
Group MAPS GFR RPF MGVh GSI
C 107k 0.37 1.09 2.2 2.4 1.4
N = 8 +4 0.03 0.07 0.1 0.1 0.4
DM 109 0.48 1.46 1.8 2.9 2.5
N = 8 +8 0.04 0.11 0.1 0.3 0.8
Nx 102 057b 172b 1.3" 33b 1.9
N = 8 +2 0.05 0.09 0.1 0.2 0.6
DM-Nx 104 081" 2.84" 0.9" 33b 54b
N = 9 +4 0.05 0.21 0.1 0.2 1.9
ax + EP, P = 0.05; b vs. C; " vs. DM; d vs. all other groups; mm
Hg; ml/min 100 g of body wt; S10 dyne . cm';" l0 mm3.
Abbreviations are: MAP, mean arterial pressure; GFR, glomerular
filtration rate.
Only DM-Nx animals showed a significant increase in GSI. Nx and
DM-Nx animals had similar increases in MGV, but GFR and RVR were
significantly higher in the latter group. Our results suggest that the
higher GSI found in DM-Nx animals was more closely related to the
hemodynamic alterations than to the magnitude of glomerular hyper-
trophy.
Renal opportunistic infection In AIDS patients. L.PJ. Marques, L.S.
Rioja, and O.R. Santos, Escola de Medicina e Cirurgia, Servico de
Medicina, Universidade do Rio de Janeiro, Rio de Janeiro, Brazil.
AIDS is characterized by a marked abnormality in cellular immunity
that predisposes to several opportunistic infections. In order to evaluate
the prevalence of these infections in the kidney, we studied the renal
tissue of 46 AIDS patients autopsied by light microscopy. We found
parenchymal renal opportunistic infections in 17 (36.9%), tuberculosis
in 11, viral infection in 3, cryptococcosis in 2, and candidiasis in 1, and
only 6 of them presented moderate microscopic hematuria, pyuria
sterile or cylindruria. Conclusions: (1) Renal opportunistic infections,
mainly tuberculosis, were common features in this series; (2) Sub-
clinical renal tuberculosis was frequent (23.9%), so urine, sputum and
blood cultures should be routinely processed for mycobacterium tuber-
culosis in endemic areas in AIDS patients presenting suspected tuber-
culosis or fever of unknown origin.
Perltoneal access in continuous ambulatory peritoneal dialysis
(CAPD)—Elght years' experience. A. Cabrita, R. Castro, C. Nogueira,
M. Pestana, and E. Xavier, Servico de Nefrologia e Servico de Cirurgia
I, Hospital Santo AntOnio, Porto, Portugal. A functioning and infec-
tion-free catheter is of great interest for the success of CAPD. During
the period 1985 through 1992, 77 catheters were implanted in 59
patients. The standard double-cuff Tenckhoff catheter was the only one
we used. The catheter implantation was in all cases surgical but until
June 1988 was performed in the median line by any surgeon of the
urgency team; the CAPD started immediately and in case of catheter
dysfunction it was surgically relocated (Technique 1); afterwards, it was
performed by I of 2 surgeons, placed laterally through the anterior
rectus, under antibiotic prophylaxis, with local omentectomy if neces-
sary and the CAPD was delayed, if possible, for 2 weeks (Technique 2).
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Technique 1
N
N = 16 Technique 2
% N
N = 61
% P(k)
Peritonitis 6 38 6 10 <0.01
Exit-site and 2 13 15 25 NS
tunnel
infections
Leakage 9 56 7 11 <0.001
Early failure 5 31 15 24 NS
Relocation! 5 31 8 13 NS
omentectomy
Fifty-seven (74%) catheters functioned after the implantation. We had
10 complete failures and 10 failures to drain. The failures were resolved
with revision in 7(35%), omentectomy in 6(30%), and with estreptoqui-
nase in 1 case. The incidence of early peritonitis was of 12/77 (15.6%),
resolved with antibiotherapy in 8 cases and implying removal of the
catheter in the remainder. Thirty-one (40%) catheters were removed
because of catheter-related complications. The main reason (52%) of
removal of catheters was the infection (peritonitis non-treatable or
recurrent, and/or tunnel infection) with 7 cases of technique I and 9 in
technique 2 (P < 0.05, ). The 1-year global actuarial survival of the
catheters was 65% and the 4-year survival was 34%. The actuarial
survival at 1 and 3 years in technique 1 was, respectively 37 and 13%.
In technique 2 those survivals were of 75% at 1 year and 53% at 4 years
(P < 0.0005, log rank test). Conclusions: (1) The technique of implan-
tation was of great influence in morbidity and survival of the catheters.
(2) The actuarial survival of the catheters at 1 year was good (75%).
Antitbymocyte globulin (ATG) cyclosporine (CsA), and methylpred-
nisolone (MP) as protocol of induction therapy in kidney transplantation
(KT). R. Castro, B. Parreira, M. Pinho, J. QueirOs, L. Lobato, T.
Morgado, C. Mota, J. Maximino, J. Pimentel, G. Rocha, J. Azevedo,
M. Oliveira, A. Castro Henriques, A. Morais Sarmento, B. Xavier, and
M. Pereira, Servico de Nefrologia, Departamento de Transpiante de
Orgaos, Hospital Santo Antonio, Porto, Portugal. In a previous study
we used a protocol with ATG, CSA, azathioprine, and MP in KT at
great immunologic risk (sensitized or second KT). The main goals of
extended use of ATG in non-sensitized patients were to reduce early
acute graft rejection and CsA nephrotoxicity. In this study we tried to
confirm the achievement of those goals and we watched for side effects
of ATG. Between July 1989 and October 1992, 83 first cadaveric KT
recipients received an induction immunosuppressive protocol that
included ATG (3-4 mg/kg) 6 hours before KT and during 7 days, CsA (6
mg/kg/day), and MP. The maintenance protocol consisted of CsA and
MP. The median follow-up was of 12.1 months (4—43 months). The
incidence of rejection during the first 3 months after KT was 20,5%. The
first episode of rejection was "delayed" to the 20.10 day (± 15.8).
Fifty-eight kidney grafts (KG) achieved immediate function. We have
lost 10 KG (12%) during the follow-up. Six never functioned (2 by
cellular rejection, 2 by renal venous thrombosis, 1 by KG necrosis with
vascular rejection on post-nephrectomy examination and 1 by death of
the recipient of a KG that was in acute tubular necrosis). The other four
KG achieved function and were lost afterwards, 1 by renal venous
thrombosis, 1 by KG rupture, I by KG necrosis and 1 by death of
recipient. Only 3 (30%) of these losses were of immunologic cause.
During the administration of ATG we observed leukopenia in 20% and
thrombocytopenia in 27% of the kidney recipients. In the first 6 months
following KT there was an incidence of 1.95 infections/patient with
salience for urinary tract infections (1.4/patient). Cytomegalovirus
infections in 51% of the patients and 5% of cytomegalovirus diseases
were recorded. None of the 4 deaths was of infectious cause and we did
not observe any neoplasia. The 1 and 3-year actuarial graft survival was
88% and the 1/3-year patient survival was 95.2/94.9%, respectively.
These results indicated that the immunosuppressive protocol with ATG
was associated with good graft and patient survivals, low incidence of
early rejections, low incidence of CsA nephrotoxicity and low levels of
morbidity and mortality.
Is the percutaneous biopsy of the solitary kidney contraindicated? J.
Bordalo, S. Colaco, F. Carvaiho, and M. da Costa, Servico de
Nefrologia, Hospital Curry Cabral, Lisboa, Portugal, Percutaneous
renal biopsy (PRB) is one of the fundamental diagnostic techniques in
nephrology. Though relatively safe, it is not without risks. Until now,
patients with solitary kidneys required open surgical biopsies. The
introduction of ultrasound guidance has allowed us to perform 21
percutaneous biopsies in 5 solitary kidneys (SK) and 16 functioning
solitary kidneys (FSK) with a PRB method which combines the use of
an automated biopsy device (Biopsy System, Bard), disposable biopsy
needle 14 g x 16 cm (17 mm specimen notch), and a 3.5 MHz linear
biopsy probe (BP) attached to the ultrasound scanner (Siemens Sono-
line SL1). The needle is passed through the BP and advanced to the
capsule under ultrasound guidance. Activation causes the obturator to
advance 23 mm into the kidney followed immediately by the cannula. In
5 SK patients, all had a previous nephrectomy. In 16 FSK patients, the
counterlateral biopsied kidney had GFR < 7 mI/mm at Tc-DTPA in 9,
no perfusion at angiography in 4, and no nephrogram at IVU in 3. In 21
patients, age 34—72 years, mean creatinine was 2.5 (0.7—6.8), and 21/21
(100%) had specimens adequate for tissue diagnosis. For each biopsy a
mean of 1.1 (1—2) needle passes was required. An average of 18
glomeruli (range 6—42) was detected per biopsy. There were only minor
complications: 1/21 had a small perinephric hemorrhage, detected by
ultrasound. No other complications were detected, particularly gross
hematuria, significant drop in hematocrit, nephrectomy or death. This
method is obviously of great help in patients presenting with solitary
kidneys or functioning solitary kidneys and is probably a better alter-
native than open surgical biopsy.
Pregnancy in renal transplant patients. A.M. Correia, J. Guerra, N.
ZOzi,no, F. Rego, J. Lopes, M.J. Sampalo, A. Gomes da Costa, and
J.R. Pena, UTR do Hospital da Cruz Vermeiha Portuguesa, Lisboa,
Portugal. Renal transplantation is usually associated with improvement
in the reproductive function. Ideally, pregnancies after transplantation
should be planned to take place when the prospective mother is in good
health, with stable renal function and normal blood pressure. We
recommend that pregnancy should be postponed until two years after
transplantation. Our study reports 8 pregnancies in renal allograft
recipients. We reviewed the impact on graft function and on acute
rejection episodes after delivery, as well as the incidence of under-
weight and premature infants. Mean patient age was 29.9 6.7 years
(17 to 40 years) and mean time between transplant and pregnancy was
3 2.4 years (3 to 6 years). Six patients were immunosuppressed with
prednisolone and cyclosporine (CsA), one with azathioprine and pred-
nisolone (AZA), and the other one with the three drugs. Mean serum
creatimnes before and after pregnancies were, respectively, 1.28 0.33
mg% and 1.46 0.46mg% without statistical differences. Spontaneous
abortion occurred once and therapeutic abortion was performed in
another patient. In two pregnancies deaths occurred "in uterus" at the
35th week. Of the remaining, one pregnancy was geinmellar. Mean time
of pregnancies was 35.2 2.75 weeks and mean weight at birth 1.086
0.283 kg. In conclusion, only 4 out of 8 pregnancies were successful,
with all infants underweight but without loss of transplant function.
Donor risk to acute tubular necrosis in renal transplantation. A.
Gomes da Costa, A.M, Correia, J. Guerra, F. Re go, J. Lopes, N.
ZOzimo, and M. Sampaio, UTR do Hospital da Cruz Vermelha Portu-
guesa, Lisbon, Portugal. Data from 220 donors, whose kidneys were
grafted to 293 patients in our unit between 1/01/1985 and 31/12/1991,
were reviewed, The following parameters were correlated to acute
tubular necrosis: procurement unit, age and donor sex, duration of
assisted ventilation, multiple or isolated organ procurement, donor
serum urea and creatinine values, and warm and cold ischemic times.
Acute renal failure was defined by the need to do hemodialysis after
transplantation. Statistical analysis was performed with Student f-test
and x2 test with Bonferroni correction factor. There was a strong
correlation of ATN with procurement unit (, = 16.725; P = 8.045;
E-4), with duration of ventilation ( = 20.55; P = 1.32; E-4), and age
of donor ( = 15.639; P = 0.015). ATN was not associated with a
worse renal function or reduced kidney survival at one year.
Rickets of renal origin. A.M. Maia, f.M. Franca, M,J. Costeira, M.
Barreira, H. Jardim, A. Caldas, and N.T. Santos, Departmento Pedi-
atrica, Hospital S. .Jodo, Porto, Portugal. The authors report a case of
a 6-year-old Caucasian male, with failure to thrive, rickets, and pro-
gressively impaired ambulation for the last 2 years. The child was born
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to a young, healthy, non-related couple, after normal full-term gesta-
tion. X-rays of the long bones revealed bone demineralization, cortical
thinning of the metaphysis and enlargement, cupping and fraying of
epiphysis. Signs of pathological fractures and deformities were present.
Investigations showed hypercioremic acidosis, renal function slightly
impaired, hypophosphatemia and TPR = 53%. Glucosuria, proteinuria
and generalized aminoaciduria were also detected. This clinical and
biochemical picture was compatible with the diagnosis of Fanconi's
syndrome; further investigation revealed a primary complex proximal
tubulopathy, which is a rare condition.
Plasmapheresis and plasma flux: A safe and efficient procedure possible
in any dialysis unit. T. Mendes, P. Maia, A. Carreira, and L.
Gonçalves, Servico de Nefrologia, Centro Hospitalar de Coimbra,
Coimbra, Portugal. A 64-year-old man was admitted to the hospital
because of acute renal failure. The diagnosis of Goodpasture's syn-
drome was made on the basis of the presence of a rapidly progressive
renal failure, pulmonary hemorrhage and circulating antiglomerular
basement membrane antibodies demonstrated in serum. Laboratory
studies, on admission, were remarkable for a serum creatinine of 635
tmo1Iliter; the presence of oligoanuria required hemodialysis. Since
there was pulmonary involvement (bilateral perihilar alveolar infiltrates
+ hemoptysis) and a positive test for circulating anti-GBM antibodies,
we decided to initiate administration of glucocorticoids and the use of
plasmapheresis (6 treatments). We used capillary plasma filter "Plas-
maflux Fresenius" (polypropylene membrane) adapted to Fresenius
2008 hemodialysis monitor, The vascular access was the double-lumen
catheter, that had been inserted for hemodialysis in the subclavian vein.
Such plasma exchange treatments involved the removal of 3 liters of
plasma per day, with replacement fluid consisting of isotonic saline
containing 4 g of albumin per dliter and fresh frozen plasma (because of
pulmonary bleeding). The replacement fluid was infused on venous line
and the filtrated plasma collected on a sterile system. We report our
results concluding that plasmapheresis with capillary plasmafilter is an
efficient and safe procedure that can be performed in any dialysis unit.
A prospective and controlled evaluation of the erythropoietin effect on
the active immunoprophylaxis against hepatitis B viral infection in
dialysis patients. G. Macedo, A.P. Chaves, F. Pinto, J. Monteiro, J.
Keating, F. Seixas, B. Carvalho, and A. Loureiro, Nefronorte, Pare-
des, Portugal. Introduction and aim: T cell immune mediation and the
humoral axis are compromised in hemodialysis patients. It has been
suggested, however, that there is a direct effect of recombinant human
erythropoietin (rHuEPO) in the CD4/CD8 subpopulation ratio and in the
immunoglobulin basal and mitogenic induced production. We have
analyzed, prospectively, the possible effect of rHuEPO in the vaccina-
tion against hepatitis B viral infection. Material and methods: For
prospective evaluation, 18 patients were selected who had recently
started on a regular hemodialysis program (previous mean time on
dialysis of 13 months); they were divided into 2 groups, matched for
time of dialysis, age (M = 42) and sex. To the rHuEPO group, this
growing factor was given 40 U/kg i.v., 3 times/week if the hematocrit
was inferior to 28% or hemoglobin < 8 g/dl. To all, Hevac B was given
in a reinforced schedule of 4 doses. Classical HBV serological markers
(RIA) were determined, one month before the first, the last dose (t1) and
one year after this one (T2). Anti-HBs titer was considered positive
whenever> 10 mIU/ml. Results: After the last dose, the anti-HBs titer
in the control group was 169 U/liter (12—423) and 199 (0—553) in the
rHuEPO group, with a non-responder (1/9, 11%) in each group. At one
year of follow-up, the titer in the control group was 270 mU/liter
(20—435) and for the rHuEPO's, it was 386 mU/liter (37—1188). In both
groups, 2/9 (22%) had a titer inferior to 100 mU/liter. Conclusions: (1)
Vaccination at the beginning of a regular hemodialysis program has a
very good seroconversion rate (89%). (2) The seroconversion rate was
similar for both groups, but the antibody titer was superior in the
rHuEPO group. (3) This finding supports the proposed improvement of
immunological reactivity attributed to erythropoietin.
Iron load and hepatotroplc viruses: Perspective in hemodialysis pa-
tients. G. Macedo, A.P. Chaves, J. Monteiro, J. Keating, F. Seixas, B.
Carvalho, and A. Loureiro, Nefronorte, Paredes, Portugal. Introduc-
tion and aim: It is difficult to have a thorough estimation of iron deposits
in hemodialysis patients, because of the known erythropoiesis dysreg-
ulation, the numerous transfusions they are submitted to, intercurrent
diseases, and frequent iterative blood loss. Ferritin is a good biochem-
ical indicator of the iron deposits for these types of patients. We
analyzed its possible association with hepatitis B (HBV) and hepatitis C
(HCV) viral infections. Material and methods: We retrospectively
analyzed 18 patients on a regular program of dialysis, at least for 4
months, 3 times/week with ferritin > 500 zg/1iter (previous to erythro-
poietin use), determining classical HBV markers on RIA and HCV with
Elisa second generation test. Non-stable patients were excluded, as
were those with non-compensated liver disease or chronic/acute infec-
tion related to dialytic procedures. Those values were compared to
those of 40 hemodialysis patients with ferritin < 500 pg/liter. Results:
Medium ferritin values of the loaded patients group were 796 pg/liter
(502—1010), having a mean age of 51, and mean dialysis time of 50
months; in the control group, these values were, respectively, 133
pg/liter, 50 years and 53 months; with anti-HCV antibody and HBV
markers (non-vaccinated), in the loaded group, the prevalence was,
respectively, 22% (4/18) and 28%, while in the control group the
prevalence was 20% (anti-HCV) and 29%. Conclusion: Through a
biochemical assumption, using ferritin, of an iron loaded status, a
higher prevalence of HCV or HBV infection was not associated in this
group of patients.
The relative importance of the presence of the NSS band in hemodial-
ysis patients with hepatitis C virus chronic infection. G. Macedo, T.
Pinto, A.P. Chaves, J. Monteiro, F. Keating, A. Seixas, B. Carvaiho,
and A. Loureiro, Nefronorte e Servico Hematologia, Hospital Santo
Antonio, Porto, Portugal. Aim: To study the correlation of the anti-
HCV positivity pattern in RIBA2 and RIBA3 tests in a population of
hemodialysis patients. Material and methods: We have studied the
blood samples from 11 patients, infected with hepatitis C virus (HCV),
in a regular program of thrice weekly hemodialysis for 12—180 months,
with mean age of 46 years old. All samples were tested by RIBA2
(Ortho) and RIBA3 (Chiron HCV SIA Prototype), to evaluate the
impact of the NS5 antigen in the positivity pattern. The aspartate
aminotransferase (AST) level was evaluated in all samples. No samples
had the clinical syndrome of acute hepatitis. Results: We detected by
RIBA2, 8/11(73%) samples with at least 2 positive bands, and in 3/11,
only one band. In RIBA3, the pattern of positivity did not change,
except in one RIBA2 indeterminate (C22-3 positive) sample, which
turned out to be negative. We detected the presence of NS5 in 3/11
(27%), and the ALT was abnormal in 4/11(36%), not exceeding 2 times
normal in any patient. Conclusions: (1) The RIBA3 test did not change
the pattern of positivity defined by the RIBA2 test. (2) Even with the
evidence of ongoing HCV infection in 2 different tests, the ALT
abnormalities were discrete and with a low prevalence.
Intermittent intravenous cyclophosphamide therapy for lupus nephritis
in childhood. R. Araujo, T. Fonseca, L. Rodrigues, A. Vilarinho, andE.
Pereira, Servico de Nefrologia Pediatrica, Hospital de Criancas, Maria
Pia, Porto, Portugal. Six girls (7 to 14 years of age) with lupus nephritis
grade IV (WHO Classifiction) were treated with pulses of i.v. cyclo-
phosphamide 1,000 mg/rn2 and scheduled to achieve clinical response.
The major indications were corticoresistant nephrotic syndrome with
active diffuse proliferative glomerulonephritis (6/6) and severe pred-
nisolone side effects (1/6). The number of pulses ranged from 3—8 and
the mean period of follow-up was 38 months. Efficacy was evaluated by
remission (2/6), partial remission (2), resistance (2), and relapse (2) of
proteinurias. Microscopic hematuria vanished in 3/5 cases. Renal
function has been normal and stable (3/6), and recovery was noted in 2
children. Hypertension (6/6) has progressively required lower doses of
antihypertensives (3/6). These children had normal levels of hemoglobin
(5/6) leukocytes (5), platelets (6), C'3 and C'4 (4). Prednisolone dosage
has been reduced from 43.3 mg/alternate day to 25.8 mg/a.d. Toxicity
was expressed by vomiting and thinning of hair (6/6), anemia, neutro-
penia and cystitis (1). Pulses of i.v. cyclophosphamide controlled
systemic lupus and proliferative diffuse glomerulonephritis following a
mean period of 38 months with mild, transient side effects. We suggest
this therapy just for refractory SLE, corticoresistant lupus nephritis and
severe prednisolone side effects.
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Chronic renal failure in children. L. Carvaiho, H. Drago, F. Macdrio,
A. Patr(cio, F. Neves, H. Gomes, and A. Jorge Correia, HUC,
Coimbra, Portugal. For the past ten years, 22 cases of chronic renal
failure (GFR < 30 mI/mm/i .73 m2) were diagnosed in children whose
ages varied from 7 months to 13 years (average age 3 years and 8
months), at the Paediatric Hospital of Coimbra. In the group aged less
than three years (N 15) the following etiologies were established:
urinary malformations (6), hereditary nephritis (4), reflux nephropathy
(RN, 2), chronic glomerulonephritis (CGN, 2). In the other group of
children, aged three or more years (N = 7), the etiologic distribution
was: RN (2), CON (1), hemolytic-uremic syndrome (1), polycystic
disease (1), cortical necrosis (1), unknown (1). We studied the rate of
progression of renal failure, children's growth, the incidence of arterial
hypertension, anemia, acid-base, and calcium disorders. Seven children
had to receive renal replacement therapy (CAPD 3; HD 4). Six of them
were later submitted for kidney transplantation.
Renal transplantation in children. A. Jorge Correia, F. Macdrio, A.
PatrIclo, H. Games, A. Mota, HUG, Coimbra, Portugal. From August
1981 to December 1992, twenty kidney transplantations (first graft),
from cadaver donors, were performed in children whose ages varied from
3 to 15 years (average 10.8 years), at the University Hospital of Coimbra.
The prior time interval on dialysis (CAPD 3; HD 17) varied from 2 days to
26 months (average 10 months). Surgical technique, immunosuppression
protocol, children's growth and survival rates are discussed. To date 6
children have lost their grafts (1st year, 1; 2nd year, 2; 5th year, 2) due to:
recurrence of hemolytic-uremic syndrome (2), acute rejection (1), chronic
rejection (3). No mortality was observed among the transplanted children.
The only death occurred when they had already returned to dialysis
therapy after graft loss secondary to acute rejection.
Lymphomas and renal disease: A report of 8 cases. M. Oliveira
Domingos, A. Vila-Lobos, D. Carvalho, 1. Pataca, M. Lea!, F.
Nolasco, J. Loureiro, F. Carvaiho, and A.M. Costa, Servico de
Nefrologia, Hospital Curry Gabral, Lisboa, Portugal. The kidney is
one of the most common extranodal sites of metastatic lymphomas. We
have retrospectively studied 8 patients with lymphomas and renal
involvement referred to our renal unit between 1986—1993: 2 cases of
Hodgkin's disease, 6 cases of non-Hodgkin's lymphoma; five males and
three females average age being 56.7 8.9 years (39—66 years). Renal
involvement led to the diagnosis of lymphoma in half of these 4 patients
who (expressed at clinical presentation) presented nephrotic syndrome
(2), renal failure and hypertension (1), and acute nephritic syndrome (1).
Nephrotic syndrome (NS) was due to minimal change lesion in I patient
and to mensagiocapillary glomerulonephritis (ON) in the other. The
presence of lymphadenopathy in the first patient led to ganglionar
histology and Hodgkin's disease was diagnosed; this patient died during
induction of chemotherapy. The patient with NS and mesangiocapillary
ON suffered an acute intestinal obstruction: an intestinal tumor was
removed and histologic features showed a non-Hodgkin's lymphoma:
the patient is on chemotherapy; the third patient was evaluated for
hypertension and renal failure was diagnosed by monoclonal 1gM A
gammopathy and a proliferative GN with cryoglobulinemia: bone
marrow aspiration and biopsy showed a non-Hodgkin's lymphoma. The
4th patient, presented a nephritic syndrome due to minimal change
lesion/segmental and focal sclerosis associated with a monoclonal 1gM
K gammopathy; a non-Hodgkin's lymphoma was diagnosed by bone
marrow aspiration and biopsy. Hematologic malignancy disease ante-
dated renal disease in 4 of these 8 patients. These presented as acute
renal failure (ARF) in two cases, NS in one and a renal mass was found
in the last one. ARF was secondary to diffuse renal infiltration with
lymphoma cells (1 immunoblastic lymphoma, I lymphoblastic lym-
phoma) which was suggested on clinical grounds and radiological
findings, not found on renal biopsy but proved in necropsy. NS was due
to secondary amiloidosis with multisystemic involvement in a patient
with Hodgkin's disease diagnosed 4 years ago and treated a year ago
with chemotherapy (MOPP). One last patient showing a renal mass
(immunoblastic lymphoma diagnosed 2.5 years ago and on chemother-
apy) suffered nephrectomy: histology revealed a carcinoma of renal
cells. Conclusions: Hematologic malignancies are associated with a
wide variety of renal lesions. In our 8 patients, renal dysfunction had no
prognostic value in their survey, as in the reviewed literature. We must
stress that during the etiologic investigation of a nephrologic syndrome
one can find an undiagnosed lymphoproliferative disease and that the
complications due to treatment may need nephrologic assistance.
Mental development In Banter's syndrome. E. Mendonca, M. Fanha,
N.L. Antunes, L. Figueira, and F.C. Rosa, Unit of Nefrologia Pediát-
rica, Laboratory de Psicologia, Hospital St. Maria, Lisboa, Portugal.
Mental retardation has been described in Bartter's syndrome. Either
normal or increased plasma volume has been reported. Increased
intracellular Na concentration in red cells has been found in different
studies. Patients and methods: In 4 patients followed over 8 years, a
complete neurological examination and mental assessment (WAIS) was
performed, respectively at 12, 17, 18, and 27 years old. Results: two
patients, diagnosed earlier in life (18 months and 3 years) and treated
since then, had a normal neurological examination and mental devel-
opment. In other patients, diagnosis and treatment were done later on
(at 14 and 19 years); severe mental retardation was found and in one of
these patients, and cortical atrophy at MRI could be observed. Conclu-
sions: Early diagnosis and treatment appear to be important to prevent
mental retardation in Bartter's syndrome. Speculation: Adverse effects
in the CNS could be related with chronic abnormalities of the intral
extracellular Na equilibrium.
Decreased urinary excretion of dopamine in an experimental model of
cyclosporln A (CsA) nephrotoxlcity. M. Pestana, M.H. Fernandes, and
P. Soares-da-Silva, Servico Farmacologia e Terapeutica, Faculdade de
Medicina, Porto, Portugal. High blood pressure is a common compli-
cation accompanying the nephrotoxic effects of cyclosporin A (CsA).
Increased tubular reabsorption of sodium, particularly at the level of the
proximal nephron, has also been shown to parallel the hypertensive
effect of CsA. There is evidence to suggest that the dopamine (DA) of
renal origin might be of importance in the control of natriuresis, namely
through inhibition of sodium reabsorption in proximal tubules. Hyper-
tension, namely the salt-sensitive forms, have been suggested to be
accompanied by a reduced urinary excretion of DA. The aim of the
present work was to study the urinary excretion of DA and of its
metabolites in an experimental model of CsA nephrotoxicity. Male
Wistar rats (N = 4) weighing 250 g were placed in metabolic cages and
allowed to stabilize for 7 days; 24 hour acidified urine samples were
collected for the quantification of DA, 3,4-dihydroxyphenylacetic acid
(DOPAC), 3-methoxytyramine (3-MT) and homovanillic acid (HVA) by
means of h.p.l.c. with electrochemical detection and of Na and K by
flame photometry. Thereafter, animals were injected with CsA (50
mg/kg s.c.) for 7 days; on the 14th day, rats were sacrificed and samples
of blood were collected for quantification of plasma catecholamines,
PRA, aldosterone, BUN, creatinine, Na, K and osmolarity. The
kidneys were also removed for histology. From the 5th day of CsA
administration onwards, a significant reduction in the urinary excretion
of DA was observed (from 17.2 0.4 to 14.6 0.74 nmol/24 hr; P <
0.05). Simultaneously, the urinary excretion of Na (from 1.96 0.13
to 0.89 0.04mmoIJ24 hr; P < 0.01) and K (from 2.54 0.12 to 1.62
0.03 mmol/24 hr; P < 0.05) were also found to be reduced; urinary
sodium was found to significantly correlate with urinary levels of DA.
Urinary osmolarity increased during the same period from 1039 83 to
1347 15 mOsm/kg H20 (P < 0.05). The morphologic study has
revealed the presence of tubular lesions compatible with the well-
known nephrotoxic effects of CsA. In conclusion, CsA nephrotoxicity
is accompanied by a significant reduction in the urinary excretion of DA
following a reduced ability to excrete sodium.
Avascular osteonecrosis (AON) In renal transplant recipients. J. Cal-
ado, S. Colaco, F. Ribeiro, A. Vila Lobos, I. Pataca, F. Nolasco, A.M.
Costa, and J.R. Pena, Unidade de Transplantacao, Hospital Curry
Cabral, Lisboa, Portugal. AON is one of the most debilitating muscu-
loskeletal complications of renal transplantation (RT). Its incidence is
reported to be as high as 15% after 3 years, appearing most often during
the first year. The influence of the age at the time of RT, duration of
chronic renal failure (CRF), time on hemodialysis (HD), renal function,
and steroid doses, were analyzed. We studied 131 patients in our
transplantation center with, at least 3 months (m) of functioning
allograft. We found 6 AON (4.6%) all appearing before the ninth month.
Three were males. The hip was affected in all patients, bilaterally in 2.
Another patient had both the hip and the knee affected. Nuclear
magnetic resonance was required to establish the diagnosis in 5 cases.
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There wasn't any significant statistical difference between patients with
AON (Gr A) and those not affected (Or B), regarding: age [Or A: X =
50 9.2 years (y); Or B: X 45.9 13.3 y), durating of CRF [Or A:
X = 91 39.7 m; Or B: X = 95 66.1 ml and time of HD [Or A: X =
45.3 32 m; Or B: X = 41.3 31 m]. At the third, sixth and tenth
months following RT serum creatinine was similar in Or A and Or B.
The average daily cumulative doses of prednisolone (PDN) given per os(3m, Gr A: X 19.9 1.8 mg; Gr B: X = 19.8 1.5 mg, P>0.05; 6
m, Or A: X = 17.4 1.7 mg; Or B: X = 17 1.2 mg, P>0.0S; 10 m,
GrA: X = 13.9 1.2mg; Or B: X = 14.4 1.1 mg,P> 0.05) and the
average daily cumulative doses of total steroids (PDN + PDN equiva-
lent of methylprednisolone i.v.)—(3 m, Or A: X = 30.4 12.2 mg; Or
B: X = 36.5 19.7 mg, F> 0.05; 6 m, Or A: X = 22.6 6.9 mg; Or
B: X = 26.8 12.2 mg, P> 0.05; 10 m, Or A: X = 17.2 4.4 mg; Or
B: X = 20 6.8 mg, P > 0.05) were not significantly different between
both groups of patients. Conclusions: The low incidence of AON (4.6%)
in our renal transplant recipients is in accordance to the recent series
that reports a reduced prevalence since the low-dose steroid regimens
were introduced. All AON were precocious (< 9 m). NMR was, in this
study, the best method of establishing the diagnosis. Age, durations of
CRF, time on HD, renal function and doses of steroids did not affect, in
this small series, the incidence of AON.
Hemorragic fever with renal syndrome: A case report of Hantavirus
disease in Portugal. J. Monteiro, M. Mesquita, and A. Filipe, Servico de
Medicina Interna, Centro Hospitalar do Vale do Sousa, Paredes, e
Centro de Estudo de Zoonoses, Inst it uto Nacional de Saáde, Aguas de
Moura, Portugal. Despite previous evidence of infection by Hantavirus
in wild rodent populations in a small area of Southern Portugal, cases of
acute human disease had not yet been recognized among us. We now
report the case of a 72 year-old man, a farmer, who lives in a small
village in the North of Portugal. He became acutely ill, with fever,
vomiting, headache, diffuse muscular pain and rectorragiae, and 3 days
later, when he sought our medical attention, he was jaundiced, had an
erythematous rash over his arms and legs, injection of the conjunctivae
and hepatomegaly. He was admitted to the hospital, and suspecting
leptospirosis, was prescribed doxycycline, while awaiting serologic
studies. Laboratory investigation revealed anemia, with hematocrit of
22% and Hgb of 7.4 g/dl, his white cell count was 17 x l09/liter with
neutrophiia of 82.5% and the platelet count was 70 x 109/liter with a
normal coagulation screen. His blood urea rose to 232 mg/dl, serum
creatinine was never higher than 4.73 mg/dl, serum aminotransferases
were about twice normal, and there was marked hyperbilirubinemia,
with total bilirubin of 23.42 mg/dl and a conjugated fraction of 17.56
mg/dl. His urine contained bile and protein, with few granular casts.
Bacteriologic studies of blood and urine revealed no infection, and
serologic tests for systemic vasculitis and infectious diseases (including
leptospirosis) were negative. Serologic study for hantavirus infection
revealed a positive 1gM response to hantavirus, making possible the
diagnosis of the first acute case of this disease in our country.
Conservative treatment of the acute non-oliguric renal failure allowed a
complete, clinical and analytical, recovery, and the patient was dis-
charged home at 4 weeks, without sequelae. This disease must be
considered in the differential diagnosis of acute renal failure of unknown
etiology, mainly if it ensues in the clinical context as previously
described.
Cognitive functions on hemodlalysis patients: Does PTH, a neurotoxin,
contribute to dementia? H. Estibeiro, S. Colaco, L. Delgado, P.
Cordeiro, M. Leal, and J.D. Barata, Sociedade Portuguesa de Didlise,
Amadora, Portugal. To investigate the effect of biologic and laboratory
parameterson the cognitive functions of hemodialysis (HD) patients, 65
HD patients were evaluated twice with one year interval (1991—1992).
The diagnosis of dementia or disturbed cognitive functions was based
on the MiniMental State Test (MMST) result, after exclusion of
depressive behavior by the Beck Inventory (B!). By the time the study
was initiated, the mean age of these patients was 55 14(18—76) years,
and the mean duration of regular hemodialytic treatment was 43 28
(17—144) months; 30 (47.7%) of these patients were female and 35
(52.3%) male. One patient with a past history of stroke and seven
regularly taking benzodiazepine or antidepressant drugs were included.
In 1991, 22 of these patients and, in 1992, 47 of them were on an
erythropoietin (EPO) program. The factors considered in the study
were: age, sex, duration of HD treatment, serum levels of aluminum,
folic acid, PTH m, hemoglobin and first week dialysis mean blood urea
before dialysis. Five of the patients (7.7%) were dementiated and 3 of
them also depressive. 17 (26%) of all the patients had a depressive
behavior, severe in 8 and moderate in 9. By multivariate analysis only
age and mean PTHm blood levels were significatively associated with
dementia. The dementiated patients were older (67.6 7.3 vs. 54.5
14.4 years old, P < 0.05) and had higher blood levels of mean PTHm
(535.4 377.4 vs. 264.8 155.8, P = 0.002). We conclude that the
mean PTH levels may contribute to disturbed cognitive functions of the
elderly patients on regular HD treatment.
Cytokine induction in hemodialysis with high-flux membranes. A.
Otero Glz, E. Armada Rdgz, J. Esteban Morcillo, and P. Gayoso,
Nephrology Hospital, Research Section, "Cristal-Piñor" Hospital,
Orense, Spain. Chronic hemodialysis (CHD) causes different side
effects, and among them a major susceptibility to infections, neutrope-
nia, and amyloidosis. The pathogenesis of these phenomena seems to
be related to cytokine production of interleukin I (IL-I) and tumoral
necrosis factor. Its activation is independent from the complement
system and it is probable that secondary phenomena to the retrofiltra-
tion can stimulate them. The aim was to evaluate the genesis of IL-l and
TNF in CHD with membranes of a high-flux and different dialytic
technique: CHD free from acetate (AFB) and conventional HD (HDV)
with a bicarbonate bath. Twelve patients were selected on CHD, 6 (5
men and 1 woman of 59 years old and 20.5 months on CHD) in AFB
with capillary dialysis machine of acrylonitrile of 1.15 m2 and coefficient
of UF: 31 mI/hr mm Hg. (Filtral 12) and 6 (4 men and 2 women
63-years-old and 40 months) in HDV with flat dialysis machine of
Polyacrilonitrile of 1.25 m2 and coefficient UF:31 mI/hr mm Hg (Crystal
3400). In all of them it was determined at the time of dialysis 0, 20, 60
and 240 minutes IL-I and TNF by enzymoimmunoanalysis and recount
of monocytes (M). The statistic methodology used was the calculus of
the average, DS and the comparison of averages by Student's 1-test.
0 mm 20 mm 60 mm 240 mm
AFB
IL-l 30.4 21° 15.6 17° 15.5 16° 20.4 16°
TNF 11.2 9 6.9 4.6 7.3 6.5 9.7 10
M 359 157 319.4 239 517 520 351 154
HDV
IL-i 34 23 21.1 15 24.5 13 24.9 16
TNF 10.9 8.5 8.7 5.85 7.1 6 13.9 116
M 402 338 349 477 293 169 262 116
a p = 0.05
There is no cytokine stimulation in AFB and the IL-l drop is due to its
capture by the membrane and although the TNF goes down, it is not
significant as its kinetics are longer, and on the contrary in HDV there
is a persistent stimulation. This may justify the use of sterile LD in
dialysis with high-flux membrane.
Lipidic profile In CAPD. Analysis of pathogenic factors. A. Otero Glz,
E. Armada Rdguez, J. Esteban Morcillo, and B. Uriel, Nephrology
Hospital, Research Section, and "Cristal-Piñor" Hospital, Orense,
Spain. The major cause of morbidity/mortality in IRT is arteriosclero-
sis, and the most important risk factors described are arterial hyperten-
sion and the lipid metabolism alterations. In CAPD the dislipemia can
be determined by the absortion of glucose from the dialysis liquid (DL).
In order to evaluate these irregularities, we selected 9 patients, five men
and four women between 57 and 53.3 years old, respectively with 25.5
months permanence on CAPD. In all of them were determined a general
cholesterol (CT), triglycerides (TO), CHDL, LDL, VLDL, apoprotein
A-I (Apo-A), apoprotein B (Apo-B), lipoprotein (a) (Lipo (a)) and
TC/HDL-C Apo-Al/Apo B, CT/HDL-C, and they correlated with each
other as the time went by on CAPD (T-CAPD), the average concentra-
tion of glucose in LD (OLD), the protein loss in DL (Pt DL) and
clearance of ApoB (CLPB). The statistical methodology used was the
calculus of the average, standard deviation and analysis of the multiple
correlation.
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X-STD T-CAPD PtDL OLD CLPA CLPB
CT
TG
C-HDL
LDL
VLDL
LIPO (a)
Apo A/Apo B
HDL/Apo A
CT/HDL
197 76
204 120
45 14
120 65
34 20
26 3
1.3 0.5
0.33 0.9
4.7 2.1
0.1
—0.3
0.07
0.3
—0.03
0.2
0.2
—0.2
—0.01
0.06
—0.14
—0.2
0.2
—0.2
0.4a
0.02
0.04
0.2
0.2
0.1
0.2
0.2
—0.2
O.4
0.02
0.04
0.2
—0.05
—0.2
0.1
—0.06
—0.2
0.2
—0.3
0.6
—0,05
0.2
—0.3
0.04
ap = 0.05
In conclusion, the lipidic profile is very atherogenic and is determined
by the GDL absorption and the peritoneal clearance of apoproteins.
Nutritional status (NS) and residual renal function in patients on Ill).
E. Armada Rguez, A. Otero Glez, andJ. Esteban Morcillo, Nephrology
Hospital, Cristal-Pinor Hospital, Orense, Spain. It is known that the
N.S. conditions and the morbidity/mortality of those patients on HD
depend on the amount of HD received (Kt/V), according to the kinetic
model of urea (MCU). The aim was to analyze the possible influence of
the FRR on the NS in a patients' group in an liD program, stable (with
no associated catabolic factors): all of them have been on dialysis with
the same membrane (AN69) and the same buffer (CO3H), periodically
evaluated following the MCV. A total number of 58 determinations was
carried out in 36 patients: KTIV, Kt/V, PCRN, TAC, FRR, Htc, CO3H,
PTHi, proteinuria, nutritional parameter (Crp, Alb, cholesterol, lym-
phocytes), and antropometrics (fold, ann mean circumference, relative
corporal weight); two groups were established according to the FRR:
(+)> 1 mI/mm (—): 0.06 mi/mm. The statistical methodology was the
mean (average) comparison by Student's t-test and the analysis of
multiple correlation. The Htc plasma levels (30.8 4.6vs. 29.9 4.09),
CO3H predialysis (22.9 2.7 vs. 22.4 3.7)and PTHi (112.8 vs. 104.8)
were similar in both groups. The PCRN was significantly correlated
with the KT/V and KtJV (P < 0.01); there was also a significant FRR
correlation with the PCRN and TAC (P < 0.01).
N KT/V Kt1V PCR TAC FRR
FRR(+) 2opat. 1.21 0.2 0.84 0.l 1.3 0.2k 77 l3 2.2 I.2
FRR(—) l6pat. 0.98 0.1 0.95 0.1 1.1 0.2 60 15 0.2 0.3
ap<
Provided that the group with FRR (+) received a lower dialysis dose
(KtJV) and its PCRN and TAC were significantly higher than the ones
from the FRR (—) group, the associated catabolic factor having been
excluded, we infer that the FRR is a decisive factor in the EN of those
patients on HD.
